Australia Preclinical Imaging Market Size & Outlook

The preclinical imaging market in Australia is expected to reach a projected revenue of US$ 34.6 million by 2033. A compound annual growth rate of 6.4% is expected of Australia preclinical imaging market from 2026 to 2033.
Revenue, 2025 (US$M)
$21.1
Forecast, 2033 (US$M)
$34.6
CAGR, 2026 - 2033
6.4%
Report Coverage
Australia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia preclinical imaging market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia preclinical imaging market highlights

  • The Australia preclinical imaging market generated a revenue of USD 21.1 million in 2025 and is expected to reach USD 34.6 million by 2033.
  • The Australia market is expected to grow at a CAGR of 6.4% from 2026 to 2033.
  • In terms of segment, modality was the largest revenue generating type in 2025.
  • Service is the most lucrative type segment registering the fastest growth during the forecast period.


Preclinical imaging market data book summary

Market revenue in 2025USD 21.1 million
Market revenue in 2033USD 34.6 million
Growth rate6.4% (CAGR from 2026 to 2033)
Largest segmentModality
Fastest growing segmentService
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationModality, Reagent, Service
Key market players worldwideBruker Corp, Siemens AG, GE Aerospace, PerkinElmer, FUJIFILM Holdings Corp, Agilent Technologies, Rigaku, TriFoil Imaging, Mediso Medical Imaging Systems, MR Solutions


Other key industry trends

  • In terms of revenue, Australia accounted for 2.0% of the global preclinical imaging market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, China preclinical imaging market is projected to lead the regional market in terms of revenue in 2033.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 63.2 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Preclinical Imaging Market Companies

Name Profile # Employees HQ Website
MR Solutions View profile 101-250 Guildford, Surrey, United Kingdom, Europe http://www.mrsolutions.com/
TriFoil Imaging View profile 11-50 Chatsworth, California, United States, North America https://www.trifoilimaging.com
Mediso Medical Imaging Systems View profile 251-500 Budapest, Budapest, Hungary, Europe https://mediso.com/
Agilent Technologies View profile 10001+ Santa Clara, California, United States, North America http://www.agilent.com
Rigaku View profile 501-1000 Akishima, Tokyo, Japan, Asia https://japan.rigaku.com/ja
PerkinElmer View profile 10001+ Waltham, Massachusetts, United States, North America http://www.perkinelmer.com
Bruker Corp View profile 9707 40 Manning Road, Billerica, MA, United States, 01821 https://www.bruker.com
FUJIFILM Holdings Corp View profile 83784 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 http://www.fujifilmholdings.com
GE Aerospace View profile 125000 One Financial Center, Suite 3700, Boston, MA, United States, 02111 https://www.geaerospace.com
Siemens AG View profile 321000 Werner-von-Siemens-Strabe 1, Munich, BY, Germany, 80333 https://www.siemens.com

Australia preclinical imaging market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to preclinical imaging market will help companies and investors design strategic landscapes.


Modality was the largest segment with a revenue share of 62.56% in 2025. Horizon Databook has segmented the Australia preclinical imaging market based on modality, reagent, service covering the revenue growth of each sub-segment from 2021 to 2033.


With ongoing developments in medical technology, rising burden of chronic diseases, aging population, growing income, and shifting consumer expectations, it is anticipated that the demand for medical applications, including preclinical imaging, will increase for all age groups. Australians have one of the highest life expectancies in the world, ranking sixth among OECD nations.

Rising investments by government organizations and market players in the country for preclinical imaging are expected to boost the demand for the required raw materials. Hence, several companies are launching innovative products and partnering with manufacturers to offer technologically advanced products.

Reasons to subscribe to Australia preclinical imaging market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia preclinical imaging market databook

  • Our clientele includes a mix of preclinical imaging market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia preclinical imaging market , including forecasts for subscribers. This country databook contains high-level insights into Australia preclinical imaging market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia Type - Preclinical Imaging Market size, 2025 - 2033 (US$M)

Australia Preclinical Imaging Market Outlook Share, 2025 & 2033 (US$M)

Australia Type - Preclinical Imaging Market size, 2025 - 2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online